• Title of article

    Use of the case-crossover design to study prolonged drug exposures and insidious outcomes

  • Author/Authors

    Philip S. Wang، نويسنده , , Sebastian Schneeweiss، نويسنده , , Robert J. Glynn، نويسنده , , Helen Mogun، نويسنده , , Jerry Avorn، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    8
  • From page
    296
  • To page
    303
  • Abstract
    Purpose The case-crossover design was originally intended to study brief exposures with immediate and transient effects, and acute outcomes with abrupt onsets. We investigated whether case-crossover methods can be used to study prolonged exposures and insidious outcomes. Methods We conducted a case-crossover study of 8220 patients aged greater-or-equal, slanted65 years enrolled in several health benefits programs in New Jersey during the period between 1991 and 1995. All had episodes of central nervous system (CNS) adverse events (e.g., delirium). Drug exposures were assessed during case time periods and control time periods lasting 1, 2, 3, or 4 months. Exposures included 3 active regimens with established deleterious CNS effects (corticosteroids, digoxin, and opiates) and 2 inactive regimens without such effects (multivitamins and statins). Results In conditional logistic regression models, significantly elevated risks were observed for all three active drugs, regardless of which time windows were used. The magnitude of these risks generally increased with longer time windows. No significantly increased risks were observed for the 2 inactive drugs, regardless of the window duration. Conclusions These results suggest that with lengthened exposure assessment windows, case-crossover methods may be useful for studying exposures with prolonged effects and outcomes with insidious onsets.
  • Keywords
    Case-crossover Design , Central Nervous System Dysfunction , Prolonged Drug Exposures
  • Journal title
    Annals of Epidemiology
  • Serial Year
    2004
  • Journal title
    Annals of Epidemiology
  • Record number

    462322